Yanka Salazar

Mrs. Yanka Salazar

Instituto René Rachou - Fundação Oswaldo Cruz
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2021 in Malaria Journal
Verified
Journal Article
Open access
PDF file
GMGISELY DE MELO
GISELY DE MELO
RNRebeca Linhares Abreu Netto
Rebeca Linhares Abreu Netto
VMVictor Irungu Mwangi
Victor Irungu Mwangi
YSYanka Salazar
Yanka Salazar
VSVANDERSON SOUZA SAMPAIO
VANDERSON SOUZA SAMPAIO
MLMarcus Vinícius Guimarães de Lacerda
Marcus Vinícius Guimarães de Lacerda
Background: Vivax malaria diagnosis remains a challenge in malaria elimination, with current point of care rapid diagnostic tests (RDT) missing many clinically significant infections because of usually lower peripheral parasitaemia. Haemozoin-detecting assays have been suggested as an alternative to immunoassay platforms but to date have not reached successful field deployment. Haemozoin is a paramagnetic crystal by-product of haemoglobin digestion by malaria parasites and is present in the food vacuole of malaria parasite-infected erythrocytes. This study aimed to compare the diagnostic capability of a new haemozoin-detecting platform, the Gazelle™ device with optical microscopy, RDT and PCR in a vivax malaria-endemic region. Methods: A comparative, double-blind study evaluating symptomatic malaria patients seeking medical care was conducted at an infectious diseases reference hospital in the western Brazilian Amazon. Optical microscopy, PCR, RDT, and Gazelle™ were used to analyse blood samples. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and Kappa values were calculated. Results: Out of 300 patients, 24 test results were excluded from the final analysis due to protocol violation (6) and inconclusive and/or irretrievable results (18). Gazelle™ sensitivity was 96.1 % (91.3–98.3) and 72.1 % (65.0–78.3) when compared to optical microscopy and PCR, respectively whereas it was 83.9 % and 62.8 % for RDTs. The platform presented specificity of 100 % (97.4–100), and 99.0 % (94.8–99.9) when compared to optical microscopy, and PCR, respectively, which was the same for RDTs. Its correct classification rate was 98.2 % when compared to optical microscopy and 82.3 % for PCR; the test’s accuracy when compared to optical microscopy was 98.1 % (96.4–99.7), when compared to RDT was 95.2 % (93.0–97.5), and when compared to PCR was 85.6 % (82.1–89.1). Kappa (95 % CI) values for Gazelle™ were 96.4 (93.2–99.5), 88.2 (82.6–93.8) and 65.3 (57.0–73.6) for optical microscopy, RDT and PCR, respectively. Conclusions: The Gazelle™ device was shown to have faster, easier, good sensitivity, specificity, and accuracy when compared to microscopy and was superior to RDT, demonstrating to be an alternative for vivax malaria screening particularly in areas where malaria is concomitant with other febrile infections (including dengue fever, zika, chikungunya, Chagas, yellow fever, babesiosis).

3 April 2024 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
YSYanka Salazar
Yanka Salazar
JLJaime Louzada
Jaime Louzada
MPMaria Carolina Silva de Barros Puça
Maria Carolina Silva de Barros Puça
LGLuiz Felipe Ferreira Guimarães
Luiz Felipe Ferreira Guimarães
JVJosé Luiz Fernandes Vieira
José Luiz Fernandes Vieira
TSTais Nobrega de Sousa
Tais Nobrega de Sousa
Primaquine (PQ) is the main drug used to eliminate dormant liver stages and prevent relapses in Plasmodium vivax malaria. It also has an effect on the gametocytes of Plasmodium falciparum ; however, it is unclear to what extent PQ affects P. vivax gametocytes. PQ metabolism involves multiple enzymes, including the highly polymorphic CYP2D6 and the cytochrome P450 reductase (CPR). Since genetic variability can impact drug metabolism, we conducted an evaluation of the effect of CYP2D6 and CPR variants on PQ gametocytocidal activity in 100 subjects with P. vivax malaria. To determine gametocyte density, we measured the levels of pvs25 transcripts in samples taken before treatment (D0) and 72 hours after treatment (D3). Generalized estimating equations (GEEs) were used to examine the effects of enzyme variants on gametocyte densities, adjusting for potential confounding factors. Linear regression models were adjusted to explore the predictors of PQ blood levels measured on D3. Individuals with the CPR mutation showed a smaller decrease in gametocyte transcript levels on D3 compared to those without the mutation ( P = 0.02, by GEE). Consistent with this, higher PQ blood levels on D3 were associated with a lower reduction in pvs25 transcripts. Based on our findings, the CPR variant plays a role in the persistence of gametocyte density in P. vivax malaria. Conceptually, our work points to pharmacogenetics as a non-negligible factor to define potential host reservoirs with the propensity to contribute to transmission in the first days of CQ–PQ treatment, particularly in settings and seasons of high Anopheles human-biting rates.

30 December 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
Laila Rowena BarbosaLaila Rowena Barbosa
Laila Rowena Barbosa
ESEmanuelle L. da Silva
Emanuelle L. da Silva
AAAnne C. G. de Almeida
Anne C. G. de Almeida
YSYanka Salazar
Yanka Salazar
ASAndré M. Siqueira
André M. Siqueira
GMGisely Cardoso De Melo
Gisely Cardoso De Melo
Background: Early recurrence of Plasmodium vivax is a challenge for malaria control in the field, particularly because this species is associated with lower parasitemia, which hinders diagnosis and monitoring through blood smear testing. Early recurrences, defined as the persistence of parasites in the peripheral blood despite adequate drug dosages, may arise from resistance to chloroquine. The objective of the study was to estimate early recurrence of P. vivax in the Brazilian Amazon by using a highly-sensitive detection method, in this case, PCR. Methods: An ultra-sensitive qPCR that targeted mitochondrial DNA was used to compare a standard qPCR that targeted 18S rDNA to detect early recurrence of P. vivax in very low densities in samples from patients treated with chloroquine. Results: Out of a total of 312 cases, 29 samples (9.3%) were characterized as recurrences, from which 3.2% (10/312) were only detected through ultra-sensitive qPCR testing. Conclusions: Studies that report the detection of P. vivax early recurrences using light microscopy may severely underestimate their true incidence.

1 April 2026 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
YSYanka Salazar
Yanka Salazar
‪R‪Antonio Mauro Rezende
‪Antonio Mauro Rezende
MPMaria C. S. B. Puça
Maria C. S. B. Puça
JLJaime Louzada
Jaime Louzada
MMMaria E. P. Mascarenhas
Maria E. P. Mascarenhas
TSTais N. de Sousa
Tais N. de Sousa
Plasmodium falciparum malaria remains a public health concern in the Brazilian Amazon, particularly among mobile and remote populations. Antimalarial drug resistance threatens elimination efforts, particularly in the Guiana Shield, which has historically been linked to the spread of resistant parasites. We analyzed 99 P . falciparum isolates collected in Roraima State, northern Brazil (2016–2020), using targeted deep sequencing. Variants were assessed in pfcrt , pfmdr1 , and pfk13 , as well as copy number variation in pfpm2 and pfpm3 , including detection of the pfpm2/3 hybrid. High coverage enabled the detection of both dominant and minority alleles. Among the 99 isolates, the pfmdr1 -NFD haplotype was found in 6% (6/99, all likely originating from Venezuela), pfcrt -C350R in 7% (7/99), and pfpm2 and pfpm3 amplifications in 5% (5/94) and 6% (6/97), respectively, and the pfpm2/3 hybrid in 4% (4/99). No validated or candidate pfk13 mutations associated with artemisinin partial resistance were detected. This study provides the first report of the pfpm2/3 hybrid and the pfmdr1 -NFD haplotype in Brazil and confirms the presence of pfcrt -C350R in isolates from the tri-border area. These variants, associated with reduced susceptibility to lumefantrine and piperaquine, suggest that parasites in northern Brazil already carry resistance markers that are prevalent in neighboring countries. These results highlight the need for continued genomic surveillance to detect early warning signals, guide treatment policies, and contain the spread of parasites with reduced susceptibility to artemisinin-based combination therapy partner drugs.

14 October 2025 in bioRxiv
Verified
Preprint
Open access
YSYanka Salazar
Yanka Salazar
‪R‪Antonio Mauro Rezende
‪Antonio Mauro Rezende
MPMaria C. S. B. Puça
Maria C. S. B. Puça
JLJaime Louzada
Jaime Louzada
MMMaria E. P. Mascarenhas
Maria E. P. Mascarenhas
TSTais N. de Sousa
Tais N. de Sousa
Plasmodium falciparum malaria remains a public health concern in the Brazilian Amazon, particularly among mobile and remote populations. Antimalarial drug resistance threatens elimination efforts, particularly in the Guiana Shield, which has historically been linked to the spread of resistant parasites. We analyzed 99 P. falciparum isolates collected in Roraima State, northern Brazil (2016–2020), using targeted deep sequencing. Variants were assessed in pfcrt , pfmdr1 , and pfk13 , and copy number variation in pfpm2 and pfpm3 , including detection of the pfpm2/3 hybrid. High coverage enabled the detection of both dominant and minority alleles. Among the 99 isolates, the pfmdr1 -NFD haplotype was found in 6% (6/99, all likely originating from Venezuela), pfcrt -C350R in 7% (7/99), and pfpm2 and pfpm3 amplifications in 5% (5/94) and 6% (6/97), respectively, and the pfpm2/3 hybrid in 4% (4/99). No validated or candidate pfk13 mutations associated with artemisinin partial resistance were detected. This study provides the first report of the pfpm2/3 hybrid and the pfmdr1 -NFD haplotype in Brazil, and confirms the presence of pfcrt -C350R in isolates from the tri-border area. These variants, associated with reduced susceptibility to lumefantrine and piperaquine, suggest that parasites in northern Brazil already carry resistance markers that are prevalent in neighboring countries. These results highlight the need for continued genomic surveillance to detect early warning signals, guide treatment policies, and contain the spread of parasites with reduced susceptibility to ACT partner drugs.

17 November 2025
Verified
Book Chapter
Closed access
PDF file
Diego MarianoDiego Mariano
Diego Mariano
MPMaria Carolina Puça
Maria Carolina Puça
YSYanka Salazar
Yanka Salazar
RLRafael Pereira Lemos
Rafael Pereira Lemos
GMGiovana C. F. Maia
Giovana C. F. Maia
RMRaquel Cardoso De Melo-Minardi
Raquel Cardoso De Melo-Minardi